Guide

Healthy aging: what the trials show, and where their evidence stops

The six levers of aging tested in humans, ranked by what the trials actually measured.

6 analyses · updated 2026-10-30

Healthy aging does not depend on any product. Among the levers tested in humans, four hold up in randomized trials: strength training, blood pressure control, adequate protein intake, and consistency maintained over several months. The others rest on statistical association or on laboratory hypothesis.

This guide gathers the analyses the School devotes to the physiology of aging. Each one starts from a question raised in consultation, follows it back to the trials that answer it, and says where the limit of what a practitioner can assert lies.

Muscle goes before the weight does

Muscle loss begins around age 30 and affects about one adult in six after 60. It does not show on the scale: weight can stay stable while lean mass falls and fat mass rises. Grip strength, walking speed and the time it takes to rise from a chair are what move, not the morning number.

Two strength sessions a week are enough in the large majority of cases for a measurable gain in strength. Useful protein intake sits between 1.0 and 1.2 g per kilogram per day, a level that ordinary eating usually reaches without supplements. A drop of more than 10% in strength between two measurements warrants medical investigation.

the screening thresholds for sarcopenia and protein doses

Blood pressure is the best demonstrated lever on the brain

Of 112 trials identified in people without dementia, 21 showed a clear result, or 19%. The best documented lever is neither a supplement nor cognitive training: it is blood pressure. In SPRINT MIND, a systolic target under 120 mmHg reduced mild cognitive impairment in 9,361 people, hazard ratio 0.81.

The gap between the lists of modifiable factors in circulation and what trials achieve comes from the nature of the data. A cohort describes an association, a trial measures an effect. On physical activity, the two best meta-analyses contradict each other, and the association disappears when activity is measured ten years before diagnosis.

the 21 positive trials and the real size of their effect

Low grade inflammation falls with training, not with a diet

A meta-analysis of twelve trials and 388 participants shows that resistance training lowers C-reactive protein, with a standardized mean difference of -0.56. On interleukin 6, the effect does not reach significance. On tumor necrosis factor alpha, it is nil. The claim is therefore true for one marker and false for another.

There is no anti-inflammatory diet in the sense of a validated protocol. Diets associated with lower C-reactive protein are made of whole foods: whole grains, vegetables, fruit, nuts, fish. Steering a coaching program on an inflammatory marker adds little, and interpreting a high value is the physician's call.

what CRP says, and what it does not say

After menopause, bone responds to intensity, not to volume

Eighty trials and more than five thousand women reach the same conclusion: exercise acts on bone density, the effect is real, and it is modest. What separates a program that changes something from one that fills time lies in the parameters. The MEDEX-OP trial used five sets of five repetitions above 80% of maximal load, twice a week.

Result: 1.9% density gained at the lumbar spine, against 0.1% for a low intensity program. Both groups improved functional performance, only one acted on bone. And the response varies by site: significant at the spine, the femoral neck and the total hip, absent at the greater trochanter.

the parameters that separate positive trials from the rest

Hormones explain less than they are made to carry

Testosterone has become the default explanation for everything that works less well after 50. The European Male Ageing Study found that only three symptoms track the level, and they are sexual: poor morning erections, reduced desire, erectile dysfunction. Fatigue and mood are linked to the level without forming a syndrome with it.

The Testosterone Trials, conducted in 788 men of mean age 72, found no significant benefit on vitality. Dosing, interpretation and any prescription are the physician's domain. What a non-physician practitioner can do comes down to three things: listen to what is described, work on strength and sleep, and refer when symptoms persist.

the symptoms that really track the level

Dose separates adaptation from wear

Moderate stress followed by a repair phase strengthens resistance capacity. Excessive stress damages. This dose law applies to every stimulus, and it gives a grid for placing a practice in the useful zone. The documented thresholds are those of international recommendations: 150 to 300 minutes of moderate activity per week, or 75 to 150 minutes of vigorous activity, plus two strength sessions.

The other fashionable stimuli do not have the same status. Studied cold baths last 2 to 5 minutes, 2 to 5 times a week, in small samples, and measure perceived exertion, not a clinical gain. Sauna is associated with lower mortality in Finnish cohorts, with no randomized trial to confirm it.

the U-shaped curve and the hierarchy of evidence

Level of evidence for the levers of aging, by type of available data and the outcome actually measured.
LeverWhat was measuredLevel of evidence
Strength trainingStrength, walking speed, lean massRandomized trials, consistent effect
Blood pressureMild cognitive impairment, SPRINT MINDRandomized trial, moderate effect
Protein intake 1.0 to 1.2 g/kg/dayMuscle mass and strengthRandomized trials
High intensity loading exerciseBone density at the spineRandomized trials, modest effect
Resistance trainingC-reactive proteinMeta-analysis, one marker out of three
Regular saunaAll cause mortalityCohorts only
Cold exposurePerceived exertion, moodSmall samples, no clinical outcome
Testosterone for fatigueVitality, FACIT-Fatigue scaleNegative randomized trial

Level of evidence for the levers of aging, by type of available data and the outcome actually measured.

The analyses in this guide

Questions

What should someone start with to age in good health?

With strength. It is the only lever whose effect is measured by randomized trials on several outcomes at once: grip strength, walking speed, lean mass, bone density at the spine and C-reactive protein. Two sessions a week are enough for a measurable gain, and consistency over several months produces more than a one-off burst of intensity.

At what age should someone start?

There is no age below which one should wait. Muscle decline begins around 30 and accelerates afterward, but the tissue still responds well at any age. In a person over 70 progression is slower, and it remains measurable.

Are anti-aging supplements worth anything?

One case is documented: correcting an established deficiency. Antioxidants provide no benefit in mortality prevention in randomized trials, and NAD+ related molecules are still evaluated on surrogate markers, not on clinical outcomes.

Can aging be measured?

Yes, but not with the precision that consumer offers promise. The two best validated measures are free: walking speed and grip strength. Epigenetic clocks can vary by several years on the same sample analyzed twice.

What are the limits for a non-physician practitioner on these topics?

Interpreting a blood panel, making a diagnosis and prescribing are the physician's domain. A practitioner can assess function, build a training and eating plan, remeasure under the same conditions, and spot the signals that require referral.